Merrimack Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Merrimack Pharmaceuticals's balance sheet done over the years? Its assets were worth $19,188,000 last year, which is less than in the previous period. 2% of Merrimack Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $441,000, which means an decrease by -25% compared compared to last year.
Debt to Assets
| 2014 | 158656000 | 260.72M | 164.33% |
|---|---|---|---|
| 2015 | 234880000 | 418.56M | 178.21% |
| 2016 | 81483000 | 334.14M | 410.08% |
| 2017 | 117326000 | 21.04M | 17.93% |
| 2018 | 88543000 | 29.72M | 33.57% |
| 2019 | 20082000 | 2.77M | 13.79% |
| 2020 | 16776000 | 770K | 4.59% |
| 2021 | 14749000 | 562K | 3.81% |
| 2022 | 19836000 | 589K | 2.97% |
| 2023 | 19188000 | 441K | 2.3% |
MACK Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 5.98M | 19.43M | 14.20M | 14.03M | 16.58M | 20.07M | 93.44M | 21.52M | 185.60M | 35.68M |
Short term investments | 12.88M | 0 | 0 | 0 | 0 | 51.19M | 0 | 0 | 0 | 88.34M |
Net receivables | 0 | 0 | 0 | 0 | 0 | 0 | 100K | 17.46M | 6.48M | 3.31M |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 102K | 14.55M | 3.71M | 101K |
Other current assets | 309K | 389K | 480K | 2.50M | 2.11M | 4.24M | 1.40M | 3.78M | 5.58M | 4.75M |
Total current assets | 19.18M | 19.82M | 14.68M | 16.54M | 18.69M | 76.10M | 95.04M | 57.43M | 201.39M | 132.09M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 0 | 0 | 0 | 0 | 0 | 2.26M | 6.46M | 15.76M | 21.91M | 14.50M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.60M | 3.60M | 3.60M |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.97M | 7.35M | 7.72M |
Long term investments | 0 | 0 | 0 | 0 | 0 | 7.42M | 10.55M | 0 | 0 | 0 |
Other non-current assets | 3.99K | 8K | 66K | 232K | 1.39M | 2.74M | 5.26M | 701K | 611K | 728K |
Total non-current assets | 3.99K | 8K | 66K | 232K | 1.39M | 12.44M | 22.28M | 24.04M | 33.48M | 26.56M |
Total assets | 19.18M | 19.83M | 14.74M | 16.77M | 20.08M | 88.54M | 117.32M | 81.48M | 234.88M | 158.65M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36.22M | 50.13M | 59.27M |
Short term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 47.11M | 0 | 13.34M |
Total current liabilities | 441K | 589K | 562K | 770K | 2.77M | 14.79M | 19.77M | 88.22M | 103.74M | 111.14M |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | 0 | 0 | 0 | 0 | 14.87M | 0 | 216.86M | 252.72M | 100.20M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 589K | 0 | 0 | 0 | 56K | 1.26M | 3.38M | 9.85M | 13.20M |
Total non-current liabilities | 0 | 589K | 0 | 0 | 0 | 14.92M | 1.26M | 245.92M | 314.82M | 149.58M |
Total liabilities | 441K | 589K | 562K | 770K | 2.77M | 29.72M | 21.04M | 334.14M | 418.56M | 260.72M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |